Risk factors for early mortality in haematological malignancy patients with pulmonary mucormycosis

Zygomycosis in Italy: A Survey of FIMUA-ECMM (Federazione Italiana Di Micopatologia Umana ed Animale and European Confederation of Medical Mycology)

(2014) L. Pagano et al.   JOURNAL OF CHEMOTHERAPY

Epidemiology and Clinical Manifestations of Mucormycosis

(2012) George Petrikkos et al.   CLINICAL INFECTIOUS DISEASES

Combination Therapy for Mucormycosis: Why, What, and How?

(2012) Brad Spellberg et al.   CLINICAL INFECTIOUS DISEASES

A Global Analysis of Mucormycosis in France: The RetroZygo Study (2005-2007)

(2012) F. Lanternier et al.   CLINICAL INFECTIOUS DISEASES

Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3)

(2012) A. Skiada et al.   HAEMATOLOGICA

Characterization of the Cellular Immune Responses to Rhizopus oryzae With Potential Impact on Immunotherapeutic Strategies in Hematopoietic Stem Cell Transplantation

(2012) Stanislaw Schmidt et al.   JOURNAL OF INFECTIOUS DISEASES

Risk factors for mortality in patients with mucormycosis

(2012) Brad Spellberg et al.   MEDICAL MYCOLOGY

Invasive Mycoses: Strategies for Effective Management

(2011) Dimitrios P. Kontoyiannis   AMERICAN JOURNAL OF MEDICINE

Mortality in Hematologic Malignancy and Hematopoietic Stem Cell Transplant Patients with Mucormycosis, 2001 to 2009

(2011) Sarah P. Hammond et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mucorales-specific T cells emerge in the course of invasive mucormycosis and may be used as a surrogate diagnostic marker in high-risk patients

(2011) L. Potenza et al.   BLOOD

How I treat mucormycosis

(2011) D. P. Kontoyiannis et al.   BLOOD

Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007

(2011) A. Skiada et al.   CLINICAL MICROBIOLOGY AND INFECTION

Factors Associated with Mortality in Transplant Patients with Invasive Aspergillosis

(2010) John W. Baddley et al.   CLINICAL INFECTIOUS DISEASES

Recent Advances in the Management of Mucormycosis: From Bench to Bedside

(2009) Brad Spellberg et al.   CLINICAL INFECTIOUS DISEASES

Delaying Amphotericin B–Based Frontline Therapy Significantly Increases Mortality among Patients with Hematologic Malignancy Who Have Zygomycosis

(2008) Georgios Chamilos et al.   CLINICAL INFECTIOUS DISEASES

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES